✦ LIBER ✦

Cisplatin-5-fluorouracil-leucovorin (PFL) as neoadjuvant therapy in patients with locally advanced squamous cell carcinoma of the head and neck. Results after long term follow-up

✍ Scribed by J. Sastre; I. García-Carbonero; C. Perezagua; I. Manrique; J. L. González-Larriba; E. Díaz-Rubio

Book ID: 110650803
Publisher: Springer Milan
Year: 2001
Tongue: Spanish
Weight: 443 KB
Volume: 3
Category: Article
ISSN: 1699-048X
DOI: 10.1007/bf02718422

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cisplatin-5-fluorouracil-leucovorin (PFL

Cisplatin-5-fluorouracil-leucovorin (PFL) as neoadyuvant therapy in patients with locally advanced squamous cell carcinoma of the head and neck. Results after long-term follow up (réplica)

📂 Article 📅 2002 🏛 Springer Milan 🌐 Spanish ⚖ 32 KB

Randomized controlled phase II compariso

Randomized controlled phase II comparison study of concurrent chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil versus CCRT with cisplatin, 5-fluorouracil, methotrexate and leucovorin in patients with locally advanced squamous cell carcinoma of the head and neck

✍ Mamoru Tsukuda; Junichi Ishitoya; Hideki Matsuda; Choichi Horiuchi; Takahide Tag 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 249 KB

Phase I trial of concurrent chemoradioth

Phase I trial of concurrent chemoradiotherapy with docetaxel, cisplatin and 5-fluorouracil (TPF) in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN)

✍ Katori, H; Tsukuda, M; Mochimatu, I; Ishitoya, J; Kawai, S; Mikami, Y; Matsuda, 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 97 KB

Analysis of efficacy and toxicity of che

Analysis of efficacy and toxicity of chemotherapy with cisplatin, 5-fluorouracil, methotrexate and leucovorin (PFML) and radiotherapy in the treatment of locally advanced squamous cell carcinoma of the head and neck

✍ Hideaki Katori; Mamoru Tsukuda; Takahide Taguchi 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 304 KB

Docetaxel, cisplatin, and 5-fluorouracil

Docetaxel, cisplatin, and 5-fluorouracil-based induction chemotherapy in patients with locally advanced squamous cell carcinoma of the head and neck : The Dana Farber Cancer Institute experience

✍ Robert Haddad; A. Dimitrios Colevas; Roy Tishler; Paul Busse; Laura Goguen; Chri 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB 👁 2 views

## Abstract ## BACKGROUND The authors conducted a series of four Phase I–II trials of high‐dose and intermediate‐dose docetaxel, cisplatin, and 5‐fluorouracil (TPF)‐based induction chemotherapy for patients with advanced squamous cell carcinoma of the head and neck (SCCHN). The chemotherapy regime

Phase I–II study with docetaxel (D), cis

Phase I–II study with docetaxel (D), cisplatin (C) and 5-fluorouracil (5-FU) in patients (pts) with locally advanced inoperable squamous cell carcinoma of the head and neck (SCCHN)

✍ D. Schrijvers; C. Van Herpen; J. Kerger; E. Joosens; C. Le Bouder; J. Castelijns 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 152 KB